Putting public health needs at the centre of antibiotic drug development to address the crisis of antimicrobial resistance (AMR).
https://gardp.org/this-is-big/
Global Antibiotic R&D Partnership (GARDP)
Loading...
Which of these can pooled procurement help reduce?
A) Medicine shortages
B) Costs
C) Procurement risks
D) All of the above
Great initiative from the ADVANCE-ID Network. Looking forward to the webinar and learning more about the upcoming open call. 👇
📍 At SADI 2026 in Argentina, GARDP joined PAHO, academic experts and health leaders to discuss financing and access to high-cost infectious disease therapies. The session highlighted the need to pair access with stewardship, surveillance and evidence generation.
🌍🎥 #ACC2026 session recordings are now available with subtitles in English, Japanese and Thai.
From discovery to clinical development, revisit expert-led discussions across antimicrobial R&D — now more accessible globally.
🔗 Watch: acc-conference.com
📊 Poll answer: D) All of the above.
Pooled procurement can help reduce medicine shortages, strengthen supply security, improve access and make healthcare budgets go further.
🎥 Curious how it works? Watch our latest REVIVE explainer video: revive.gardp.org/resource/poo...
🤝 GARDP is proud to join forces with @dndi.org and @mmv.org to strengthen coordination, share expertise and accelerate the development of life-saving treatments for people worldwide.
📄 Learn more: gardp.org/dndi-gardp-a...
#PressRelease @dndi.org, @gardp.bsky.social and MMV are joining forces to strengthen collaboration, maximize the impact of global health R&D, and accelerate the development of life-saving treatments.
Read the press release: bit.ly/4fo8xu0
As global health budgets shrink, three Geneva-based non-profit R&D groups — @dndi.org, @gardp.bsky.social. & @mmv.org — are joining forces to accelerate lifesaving medicines for malaria, NCDs & antimicrobial resistance.
✍️ @kerrycullinan.bsky.social
📰➡️ healthpolicy-watch.news/non-profit-r...
🔬Of 10,000 compounds entering early antibiotic research, only 1 or 2 will ever reach patients.
Can AI improve those odds?
A new #REVIVE Antimicrobial Viewpoint explores how AI is reshaping antibiotic discovery & why innovation alone isn't enough to tackle #AMR.
📖 revive.gardp.org/ai-is-revivi...
